Adiuvo Investments S.A. (ADV.WA)
PLN 1.14
(4.61%)
PLN 1.14
(4.61%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 45.77 Million PLN | -17.63% |
| 2022 | 55.57 Million PLN | 12.71% |
| 2021 | 49.31 Million PLN | 17.32% |
| 2020 | 42.03 Million PLN | 43.89% |
| 2019 | 29.21 Million PLN | 1.57% |
| 2018 | 28.75 Million PLN | 87.06% |
| 2017 | 15.37 Million PLN | -25.9% |
| 2016 | 20.74 Million PLN | -17.87% |
| 2015 | 25.26 Million PLN | 20.79% |
| 2014 | 20.91 Million PLN | 67.32% |
| 2013 | 12.5 Million PLN | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 32.36 Million PLN | -27.52% |
| 2024 Q1 | 44.65 Million PLN | -2.44% |
| 2023 Q2 | 59.87 Million PLN | 4.2% |
| 2023 FY | 45.77 Million PLN | -17.63% |
| 2023 Q4 | 45.77 Million PLN | -28.28% |
| 2023 Q3 | 63.82 Million PLN | 6.6% |
| 2023 Q1 | 57.46 Million PLN | 3.4% |
| 2022 FY | 55.57 Million PLN | 12.71% |
| 2022 Q1 | 51.3 Million PLN | 4.05% |
| 2022 Q4 | 55.57 Million PLN | -1.09% |
| 2022 Q3 | 56.19 Million PLN | 3.67% |
| 2022 Q2 | 54.19 Million PLN | 5.63% |
| 2021 Q4 | 49.31 Million PLN | 5.19% |
| 2021 FY | 49.31 Million PLN | 17.32% |
| 2021 Q2 | 44.28 Million PLN | -6.84% |
| 2021 Q1 | 47.54 Million PLN | 13.11% |
| 2021 Q3 | 46.87 Million PLN | 5.84% |
| 2020 Q4 | 42.03 Million PLN | -4.03% |
| 2020 Q3 | 43.79 Million PLN | 8.78% |
| 2020 Q1 | 33.54 Million PLN | 14.85% |
| 2020 FY | 42.03 Million PLN | 43.89% |
| 2020 Q2 | 40.26 Million PLN | 20.01% |
| 2019 Q2 | 27.63 Million PLN | 4.09% |
| 2019 Q3 | 29.36 Million PLN | 6.24% |
| 2019 Q4 | 29.21 Million PLN | -0.52% |
| 2019 FY | 29.21 Million PLN | 1.57% |
| 2019 Q1 | 26.55 Million PLN | -7.67% |
| 2018 Q4 | 28.75 Million PLN | -21.56% |
| 2018 FY | 28.75 Million PLN | 87.06% |
| 2018 Q3 | 36.66 Million PLN | 23.86% |
| 2018 Q2 | 29.6 Million PLN | 29.31% |
| 2018 Q1 | 22.89 Million PLN | 48.91% |
| 2017 Q1 | 21.27 Million PLN | 2.54% |
| 2017 FY | 15.37 Million PLN | -25.9% |
| 2017 Q4 | 15.37 Million PLN | -38.35% |
| 2017 Q3 | 24.93 Million PLN | 16.9% |
| 2017 Q2 | 21.33 Million PLN | 0.26% |
| 2016 FY | 20.74 Million PLN | -17.87% |
| 2016 Q4 | 20.74 Million PLN | 5.06% |
| 2016 Q2 | 18.76 Million PLN | 6.17% |
| 2016 Q1 | 17.67 Million PLN | -30.03% |
| 2016 Q3 | 19.74 Million PLN | 5.22% |
| 2015 Q1 | 21.03 Million PLN | 0.55% |
| 2015 Q2 | 20.61 Million PLN | -2.01% |
| 2015 Q4 | 25.26 Million PLN | 19.69% |
| 2015 Q3 | 21.1 Million PLN | 2.42% |
| 2015 FY | 25.26 Million PLN | 20.79% |
| 2014 Q4 | 20.91 Million PLN | 0.0% |
| 2014 FY | 20.91 Million PLN | 67.32% |
| 2013 FY | 12.5 Million PLN | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Genomtec S.A. | 4.45 Million PLN | -928.719% |
| Medinice S.A. | 1.51 Million PLN | -2923.646% |
| Medicalgorithmics S.A. | 29.06 Million PLN | -57.502% |
| Synektik Spólka Akcyjna | 146.03 Million PLN | 68.652% |